Xponance, Inc. 23and Me Holding Co. Transaction History

Xponance, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$0.71 - $0.97 $1,168 - $1,596	1,646 Added 10.62%	17,151 $15,000
Q3 2023 Oct 23, 2023	BUY	$0.96 - $2.01 $745 - $1,561	777 Added 5.28%	15,505 $15,000
Q4 2022 Jan 23, 2023	BUY	$2.06 - $3.47 $352 - $593	171 Added 1.17%	14,728 $0
Q3 2022 Oct 24, 2022	BUY	$2.6 - $5.12 $37,848 - $74,531	14,557 New	14,557 $42,000

116

82.6M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.